VF
ANVS icon

Virtu Financial’s Annovis Bio ANVS Stock Holding History

Virtu Financial’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,333
Closed -$91K – 1600
2025
Q4 		$91K Buy
+26,333
New +$79.2K ﹤0.01% 1220
2021
Q4 		– Sell
-11,547
Closed -$367K – 1676
2021
Q3 		$367K Sell
11,547
-5,895
-34% -$339K 0.03% 614
2021
Q2 		$1.49M Buy
17,442
+9,491
+119% +$439K 0.15% 116
2021
Q1 		$222K Buy
+7,951
New +$170K 0.02% 1014

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Virtu Financial's ANVS Position: Q1 2026 in Review

Virtu Financial sold out of Annovis Bio (ANVS) in Q1 2026, closing a stake of 26,333 shares — an estimated $91K sold.

Virtu Financial first reported a position in ANVS in Q1 2021 and held it in 4 quarters. The position peaked at $1.49M in Q2 2021. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • Virtu Financial reported no remaining Annovis Bio position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 26,333 Annovis Bio shares in Q1 2026, an estimated $91K.
  • Virtu Financial first reported a position in Annovis Bio in Q1 2021 and held it in 4 quarters.
  • Virtu Financial's Annovis Bio position peaked at $1.49M in Q2 2021.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.